2-(4-Meth-oxy-phen-yl)-1-phenyl-1H-benzimidazole

Overview

Journal Acta Crystallogr Sect E Struct Rep Online

Date 2013 Feb 21

PMID 23424544

Authors

T Mohandas

K Jayamoorthy

J Jayabharathi

P Sakthivel

Affiliations

Soon will be listed here.

Abstract

In the title compound, C(20)H(16)N(2)O, the 1H-benzimidazole ring forms dihedral angles of 48.00 (6) and 64.48 (6)°, respectively with the benzene and phenyl rings, which are inclined to one another by 58.51 (7)°. In the crystal, weak C-H⋯π inter-actions are the only inter-molecular inter-actions present.

References

Beaulieu P, Bos M, Bousquet Y, Fazal G, Gauthier J, Gillard J . Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives. Bioorg Med Chem Lett. 2003; 14(1):119-24. DOI: 10.1016/j.bmcl.2003.10.023. View

Tomei L, Altamura S, Bartholomew L, Biroccio A, Ceccacci A, Pacini L . Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Virol. 2003; 77(24):13225-31. PMC: 296079. DOI: 10.1128/jvi.77.24.13225-13231.2003. View

Pawar N, Dalal D, Shimpi S, Mahulikar P . Studies of antimicrobial activity of N-alkyl and N-acyl 2-(4-thiazolyl)-1H-benzimidazoles. Eur J Pharm Sci. 2004; 21(2-3):115-8. DOI: 10.1016/j.ejps.2003.09.001. View

Spek A . Structure validation in chemical crystallography. Acta Crystallogr D Biol Crystallogr. 2009; 65(Pt 2):148-55. PMC: 2631630. DOI: 10.1107/S090744490804362X. View

Mason J, Morize I, Menard P, Cheney D, Hulme C, Labaudiniere R . New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. J Med Chem. 1999; 42(17):3251-64. DOI: 10.1021/jm9806998. View

Roth T, Morningstar M, Boyer P, Hughes S, Buckheit Jr R, Michejda C . Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. J Med Chem. 1998; 40(26):4199-207. DOI: 10.1021/jm970096g. View

Minoura H, Takeshita S, Ita M, Hirosumi J, Mabuchi M, Kawamura I . Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614. Eur J Pharmacol. 2004; 494(2-3):273-81. DOI: 10.1016/j.ejphar.2004.04.038. View

Sheldrick G . A short history of SHELX. Acta Crystallogr A. 2007; 64(Pt 1):112-22. DOI: 10.1107/S0108767307043930. View

Morningstar M, Roth T, Farnsworth D, Smith M, Watson K, Buckheit Jr R . Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme. J Med Chem. 2007; 50(17):4003-15. PMC: 3057568. DOI: 10.1021/jm060103d. View

10.

Demirayak S, Abu Mohsen U, Karaburun A . Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives. Eur J Med Chem. 2002; 37(3):255-60. DOI: 10.1016/s0223-5234(01)01313-7. View

11.

Rao A, Carbone A, Chimirri A, De Clercq E, Monforte A, Monforte P . Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. Farmaco. 2003; 58(2):115-20. DOI: 10.1016/s0014-827x(02)00024-1. View